These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27591792)

  • 1. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition.
    Osajima T; Hoshino T
    Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Binding Modes of Antigen-Antibody Complexes by Molecular Mechanics Calculation.
    Qu L; Qiao X; Qi F; Nishida N; Hoshino T
    J Chem Inf Model; 2021 May; 61(5):2396-2406. PubMed ID: 33934602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational and statistical study on the molecular interaction between antigen and antibody.
    Osajima T; Suzuki M; Neya S; Hoshino T
    J Mol Graph Model; 2014 Sep; 53():128-139. PubMed ID: 25123651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
    Tsuchiya Y; Mizuguchi K
    Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.
    Wang X; Singh SK; Kumar S
    Pharm Res; 2010 Aug; 27(8):1512-29. PubMed ID: 20422267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies.
    Fernández-Quintero ML; Kroell KB; Grunewald LJ; Fischer AM; Riccabona JR; Liedl KR
    MAbs; 2022; 14(1):2024118. PubMed ID: 35090383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Framework Residue H71 Results in Different Antibody Paratope States in Solution.
    Fernández-Quintero ML; Kroell KB; Hofer F; Riccabona JR; Liedl KR
    Front Immunol; 2021; 12():630034. PubMed ID: 33737932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
    Barrios Y; Jirholt P; Ohlin M
    J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
    Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
    J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repertoire Analysis of Antibody CDR-H3 Loops Suggests Affinity Maturation Does Not Typically Result in Rigidification.
    Jeliazkov JR; Sljoka A; Kuroda D; Tsuchimura N; Katoh N; Tsumoto K; Gray JJ
    Front Immunol; 2018; 9():413. PubMed ID: 29545810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics.
    Zhao G; Richaud AD; Williamson RT; Feig M; Roche SP
    ACS Chem Biol; 2024 Jul; 19(7):1583-1592. PubMed ID: 38916527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDR-H3 loop ensemble in solution - conformational selection upon antibody binding.
    Fernández-Quintero ML; Kraml J; Georges G; Liedl KR
    MAbs; 2019; 11(6):1077-1088. PubMed ID: 31148507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
    Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
    PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The origin of CDR H3 structural diversity.
    Weitzner BD; Dunbrack RL; Gray JJ
    Structure; 2015 Feb; 23(2):302-11. PubMed ID: 25579815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.